Literature DB >> 21802066

Understanding obesity and endometrial cancer risk: opportunities for prevention.

Rosemarie E Schmandt1, David A Iglesias, Ngai Na Co, Karen H Lu.   

Abstract

Worldwide, obesity has become a major public health crisis. Overweight and obesity not only increase the risk of cardiovascular disease and type-2 diabetes mellitus but also are now known risk factors for a variety of cancer types. Among all cancers, increasing body mass index is associated most strongly with endometrial cancer incidence and death. The molecular mechanisms underlying how adipose tissue and obesity contribute to the pathogenesis of endometrial cancer are becoming better understood and have revealed a number of rational strategies, both behavioral and pharmaceutical, for the prevention of both primary and recurrent disease.
Copyright © 2011. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21802066      PMCID: PMC4264838          DOI: 10.1016/j.ajog.2011.05.042

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  82 in total

1.  Pharmacological studies of a new oral hypoglycemic drug.

Authors:  G UNGAR; L FREEDMAN; S L SHAPIRO
Journal:  Proc Soc Exp Biol Med       Date:  1957-05

2.  Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece.

Authors:  Eleni Petridou; Christos Mantzoros; Nick Dessypris; Panagiotis Koukoulomatis; Carol Addy; Zannis Voulgaris; George Chrousos; Dimitrios Trichopoulos
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

Review 3.  S-palmitoylation modulates estrogen receptor alpha localization and functions.

Authors:  Maria Marino; Paolo Ascenzi; Filippo Acconcia
Journal:  Steroids       Date:  2005-11-07       Impact factor: 2.668

Review 4.  AMP-activated protein kinase signaling in metabolic regulation.

Authors:  Yun Chau Long; Juleen R Zierath
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

5.  Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women.

Authors:  E Salazar-Martínez; E C Lazcano-Ponce; G G Lira-Lira; P Escudero-De los Rios; J Salmerón-Castro; F Larrea; M Hernández-Avila
Journal:  Cancer Causes Control       Date:  2000-09       Impact factor: 2.506

6.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

7.  Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.

Authors:  Emily J Fearnley; Louise Marquart; Amanda B Spurdle; Philip Weinstein; Penelope M Webb
Journal:  Cancer Causes Control       Date:  2010-10-17       Impact factor: 2.506

8.  The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk.

Authors:  Wanqing Wen; Qiuyin Cai; Yong-Bing Xiang; Wang-Hong Xu; Zhi Xian Ruan; Jiarong Cheng; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

9.  Antidiabetic therapies affect risk of pancreatic cancer.

Authors:  Donghui Li; Sai-Ching J Yeung; Manal M Hassan; Marina Konopleva; James L Abbruzzese
Journal:  Gastroenterology       Date:  2009-04-16       Impact factor: 22.682

10.  Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

Authors:  Sao Jiralerspong; Shana L Palla; Sharon H Giordano; Funda Meric-Bernstam; Cornelia Liedtke; Chad M Barnett; Limin Hsu; Mien-Chie Hung; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

View more
  79 in total

1.  Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study.

Authors:  Divya Seth; Hans Garmo; Annette Wigertz; Lars Holmberg; Niklas Hammar; Ingmar Jungner; Mats Lambe; Göran Walldius; Mieke Van Hemelrijck
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

2.  Endometrial cancer.

Authors:  Kimberly K Leslie; Kristina W Thiel; Michael J Goodheart; Koen De Geest; Yichen Jia; Shujie Yang
Journal:  Obstet Gynecol Clin North Am       Date:  2012-06       Impact factor: 2.844

3.  CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.

Authors:  Qian Zhang; Rosemarie Schmandt; Joseph Celestino; Adrienne McCampbell; Melinda S Yates; Diana L Urbauer; Russell R Broaddus; David S Loose; Gregory L Shipley; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

4.  Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.

Authors:  A S McCampbell; M L Mittelstadt; R Dere; S Kim; L Zhou; B Djordjevic; P T Soliman; Q Zhang; C Wei; S D Hursting; K H Lu; R R Broaddus; C L Walker
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

Review 5.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

6.  PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.

Authors:  Shannon N Westin; Zhenlin Ju; Russell R Broaddus; Camilla Krakstad; Jane Li; Navdeep Pal; Karen H Lu; Robert L Coleman; Bryan T Hennessy; Samuel J Klempner; Henrica M J Werner; Helga B Salvesen; Lewis C Cantley; Gordon B Mills; Andrea P Myers
Journal:  Mol Oncol       Date:  2015-05-16       Impact factor: 6.603

7.  Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer.

Authors:  Koji Matsuo; Marc R Gualtieri; Sigita S Cahoon; Carrie E Jung; Richard J Paulson; Donna Shoupe; Laila I Muderspach; Akihiko Wakatsuki; Jason D Wright; Lynda D Roman
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

8.  Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response.

Authors:  Katherine E Tierney; Lingyun Ji; Shannon S Dralla; Eunjeong Yoo; Annie Yessaian; Huyen Q Pham; Lynda Roman; Richard Sposto; Paulette Mhawech-Fauceglia; Yvonne G Lin
Journal:  Gynecol Oncol       Date:  2016-10-19       Impact factor: 5.482

9.  The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Petra Pirkova; Pavla Libalova; Zdenka Vernerova; Bohuslav Svoboda; Eduard Kucera
Journal:  DNA Cell Biol       Date:  2013-11-27       Impact factor: 3.311

Review 10.  Can mHealth Revolutionize the Way We Manage Adult Obesity?

Authors:  Niharika N Bhardwaj; Bezawit Wodajo; Keerthi Gochipathala; David P Paul; Alberto Coustasse
Journal:  Perspect Health Inf Manag       Date:  2017-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.